Fundraising Fox
/People
Sign in

Sean McDonald

Founder

Chief Executive Officer at Ocugenix

Greater Pittsburgh Region

FoundedOcugenix

Find your path to Sean

414 people in our graph share verified history with Sean — schools, employers, funds. One of them is your warm intro.

Daniel GrafunlockedSean: together at Respironics (2002–2005)
×11Sean: together at Respironics

About

Sean McDonald is Co-founder, President, and CEO of Ocugenix, where he has led the development of a new chemical entity for treating wet macular degeneration from chemical discovery through a completed Phase I study, following receipt of an IND from the FDA in 2023. He previously served as President and CEO of Precision Therapeutics, Group President at McKesson, Chairman of Aethon, and founder of Automated Healthcare, which was sold to McKesson. Over the course of his career he has raised more than $200 million in venture capital across multiple companies in the health care and technology sectors.

Chief Executive Officer at Ocugenix

Experience

  1. OcugenixPresident & CEOcurrent2016 — presentGreater Pittsburgh Region
  2. Carnegie Mellon UniversityEntrepreneur in Residencecurrent2019 — presentPittsburgh, Pennsylvania, United States
  3. AccuStemBoard Membercurrent2022 — presentGreater London, England, United Kingdom
  4. ImpriMed, Inc.Boardcurrent2020 — presentSan Francisco Bay Area
  5. Various CompaniesTurnaround Executivecurrent2018 — presentGreater Pittsburgh Region
  6. AethonDirector2006 — 2017
  7. Adams Capital ManagementVenture Partner2015 — 2016Greater Pittsburgh Region
  8. Precision TherapeuticsPresident and CEO2001 — 2014
  9. RespironicsDirector, Member of the Board2002 — 2008
  10. McKessonGroup President1996 — 2000
  11. Automated HealthcareFounder, President & CEO1989 — 1996

Skills & more

Drug DevelopmentProduct ManagementEntrepreneurship1Clinical DevelopmentClinical TrialsRegulatory AffairsProduct Development28Venture Capital23Growth Management4Sales8Commercialization15Finance4
+11 moreFundraisingBiotechnologyMedical DevicesLifesciencesHealthcareStart-upsHospitalsMolecular DiagnosticsLeadershipManagementStrategy

From Sean's professional profile.

Frequently asked questions

Who is Sean McDonald?
Sean McDonald is Co-founder, President, and CEO of Ocugenix, where he has led the development of a new chemical entity for treating wet macular degeneration from chemical discovery through a completed Phase I study, following receipt of an IND from the FDA in 2023. He previously served as President and CEO of Precision Therapeutics, Group President at McKesson, Chairman of Aethon, and founder of Automated Healthcare, which was sold to McKesson. Over the course of his career he has raised more than $200 million in venture capital across multiple companies in the health care and technology sectors.
Where does Sean McDonald work?
Sean McDonald is Chief Executive Officer of Ocugenix.
What companies did Sean McDonald found?
Sean McDonald founded Ocugenix.
Where did Sean McDonald go to school?
Sean McDonald studied at Carnegie Mellon University - Tepper School of Business (Courses towards a MBA); University of Florida (MSc, Computer Science Engineering); University of Pennsylvania (BS, Chemical Engineering).

Founder mafias

Adams Capital Management mafia2

Also came through, then founded or led a company.

George UgrasGeneral PartnerFounded Cytegen

ImpriMed mafia2

Also came through, then founded or led a company.

Jeffrey LeeInvestorFounded Discovery Ventures

Same school

Shared employers

Also worked at Adams Capital Management1

George UgrasGeneral Partner at AV8 Ventures